---
figid: PMC5427056__nihms-739689-f0001
figtitle: 'Molecular Pathways: Increased Susceptibility to Infection Is a Complication
  of mTOR Inhibitor Use in Cancer Therapy'
organisms:
- Staphylococcus aureus
- Streptomyces hygroscopicus
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
- Drosophila melanogaster
organisms_ner:
- Drosophila melanogaster
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC5427056
filename: nihms-739689-f0001.jpg
figlink: /pmc/articles/PMC5427056/figure/F1/
number: F1
caption: The mTOR protein exists in two structurally and functionally distinct complexes;
  mTOR complex 1 (mTORC1) contains the mTOR kinase, mLST8, RAPTOR and the inhibitory
  PRAS40 whereas mTOR complex 2 (mTORC2) contains mTOR, mLST8, RICTOR, mSIN1, and
  PROTOR. DEPTOR inhibits both mTOR complexes and is degraded upon their activation.
  Upstream of mTOR, the GTPase RHEB is a positive regulator of mTOR activity. Immediately
  upstream of RHEB is the key negative regulator TSC which inactivates RHEB through
  its GAP (GTPase activating protein) activity. The activation of mTOR results in
  protein and lipid synthesis, autophagy, and ribosome biogenesis. Red indicates inhibitory
  function and blue and black indicate stimulatory activity with respect to the PI3KAKT-mTOR
  signaling axis.
papertitle: 'Molecular Pathways: Increased Susceptibility to Infection Is a Complication
  of mTOR Inhibitor Use in Cancer Therapy.'
reftext: Adrian M. Eiden, et al. Clin Cancer Res. ;22(2):277-283.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9500279
figid_alias: PMC5427056__F1
figtype: Figure
redirect_from: /figures/PMC5427056__F1
ndex: f85f2531-def5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5427056__nihms-739689-f0001.html
  '@type': Dataset
  description: The mTOR protein exists in two structurally and functionally distinct
    complexes; mTOR complex 1 (mTORC1) contains the mTOR kinase, mLST8, RAPTOR and
    the inhibitory PRAS40 whereas mTOR complex 2 (mTORC2) contains mTOR, mLST8, RICTOR,
    mSIN1, and PROTOR. DEPTOR inhibits both mTOR complexes and is degraded upon their
    activation. Upstream of mTOR, the GTPase RHEB is a positive regulator of mTOR
    activity. Immediately upstream of RHEB is the key negative regulator TSC which
    inactivates RHEB through its GAP (GTPase activating protein) activity. The activation
    of mTOR results in protein and lipid synthesis, autophagy, and ribosome biogenesis.
    Red indicates inhibitory function and blue and black indicate stimulatory activity
    with respect to the PI3KAKT-mTOR signaling axis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Crtc
  - Mt2
  - Tie
  - Ras85D
  - InR
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pdk1
  - grb
  - Mtor
  - Tor
  - Sos
  - rictor
  - Pten
  - Nf1
  - ras
  - Ras64B
  - Akt
  - Low
  - Raf
  - SNF4Agamma
  - AMPKalpha
  - Tsc1
  - hp
  - Dsor1
  - Mtk
  - Rheb
  - Erk7
  - rl
  - raptor
  - S6k
  - SREBP
  - Atg1
  - Thor
  - eIF4B
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - 14-3-3zeta
  - 14-3-3epsilon
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - foxo
  - Mtnr1b
  - Irs1
  - Pik3r1
  - Pdpk1
  - Mlst8
  - Rictor
  - Deptor
  - Hras
  - Kras
  - Rem1
  - Akt1
  - Sgk1
  - Prkca
  - .na.character
  - Zhx2
  - Hp
  - Mdk
  - Ephb2
  - Mapk1
  - Rptor
  - Rps6kb1
  - Srebf1
  - Ulk1
  - Eif4ebp1
  - Eif4b
  - Eif4e
  - Sfn
  - Foxo1
  - Foxo3
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - MTOR
  - RPTOR
  - MAPKAP1
  - RICTOR
  - MLST8
  - MT2A
  - MTNR1B
  - TMPRSS6
  - IRS1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDPK1
  - XYLT2
  - SOS1
  - SOS2
  - PTEN
  - NF1
  - DEPTOR
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - SGK1
  - PRKCA
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - TSC1
  - CCL26
  - HP
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - RHEB
  - RHEBP1
  - EPHB2
  - MAPK1
  - MAPK3
  - MTG1
  - RPS6KB1
  - SREBF1
  - ULK1
  - EIF4EBP1
  - EIF4B
  - EIF4E
  - EIF4E2
  - EIF4E3
  - YWHAQ
  - FOXO1
  - FOXO3
  - mt2
  - mtnr1ba
  - kita
  - ngfra
  - irs1
  - pdk1
  - cfap298
  - mtor
  - mlst8
  - rictorb
  - ptenb
  - nf1a
  - deptor
  - rab1ab
  - sgk1
  - tsc1b
  - rheb
  - rhebl1
  - ulk1b
  - eif4bb
  - eif4ba
  - eif4e1b
  - eif4ea
  - foxo1a
  - foxo3a
  - Rapamycin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
